U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sufentanil Citrate Injection
Status: Currently in Shortage
»Date first posted: 05/03/2022
»Therapeutic Categories: Analgesia/Addiction; Pediatric

Expand all

Hikma Pharmaceuticals USA, Inc. (Reverified 07/01/2024)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-01) Unavailable Not currently manufactured Demand increase for the drug
Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-02) Unavailable Not currently manufactured Demand increase for the drug
Sufentanil Citrate Injection, USP, Injection, 50 mcg/1 mL (NDC 17478-050-05) Unavailable Not currently manufactured Demand increase for the drug

Hospira, Inc., a Pfizer Company (Revised 07/15/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 50 ug/1 mL (NDC 0409-3382-21) Limited Availability Limited Supply Available. Next Delivery: July 2024; Estimated Recovery: September 2024

Dear Customer Letter (HYPERLINK)

Delay in shipping of the drug
Back to Top